A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects
Clinical trial NCT05955027 · COMPLETED
Trial details
- NCT number
- NCT05955027
- Sponsor
- Nanjing Zenshine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-08
- Primary completion
- 2023-08-05
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.